CDMRP Breast Cancer Breakthrough Award Levels 3 and 4

קרןUS Department of Defense
סוגResearch Grants
תאריך אחרון15/05/2018
פקולטהLife Sciences, Medicine

Research supported by the Breakthrough Award will have the potential for a major impact and accelerate progress toward ending breast cancer. The impact may be near-term or long-term, but must be significant and move beyond an incremental advancement. Applications must articulate the pathway to making a clinical impact for individuals with, or at risk for, breast cancer, even if clinical impact is not an immediate outcome.


Level 3:
Advanced translational studies that have potential for near-term clinical investigation. Small-scale clinical trials may apply.
Funding : $2,500,000 total ($4M with a partner)


Level 4: 
Large-scale projects that will transform and revolutionize the clinical management and/or prevention of breast cancer. Near-term clinical impact is expected.
PIs are expected to have experience in successfully leading large-scale projects.
Funding: $10,000,000 total 


Duration: 4 years


Research Authority due date: 8.5.18

Pre proposal (required) due date: 15.5.18
Full proposal due date: 14.8.18

קבצים מצורפים
עדכון אחרוןעדכון אחרון: 09/04/2018
אוניברסיטת תל-אביב, ת.ד. 39040, תל-אביב 6997801
UI/UX Basch_Interactive